• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MMSET 组蛋白甲基转移酶在 t(4;14)多发性骨髓瘤细胞中切换全局组蛋白甲基化并改变基因表达。

The MMSET histone methyl transferase switches global histone methylation and alters gene expression in t(4;14) multiple myeloma cells.

机构信息

Division of Hematology/Oncology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.

出版信息

Blood. 2011 Jan 6;117(1):211-20. doi: 10.1182/blood-2010-07-298349. Epub 2010 Oct 25.

DOI:10.1182/blood-2010-07-298349
PMID:20974671
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3037745/
Abstract

The multiple myeloma SET domain (MMSET) protein is overexpressed in multiple myeloma (MM) patients with the translocation t(4;14). Although studies have shown the involvement of MMSET/Wolf-Hirschhorn syndrome candidate 1 in development, its mode of action in the pathogenesis of MM is largely unknown. We found that MMSET is a major regulator of chromatin structure and transcription in t(4;14) MM cells. High levels of MMSET correlate with an increase in lysine 36 methylation of histone H3 and a decrease in lysine 27 methylation across the genome, leading to a more open structural state of the chromatin. Loss of MMSET expression alters adhesion properties, suppresses growth, and induces apoptosis in MM cells. Consequently, genes affected by high levels of MMSET are implicated in the p53 pathway, cell cycle regulation, and integrin signaling. Regulation of many of these genes required functional histone methyl-transferase activity of MMSET. These results implicate MMSET as a major epigenetic regulator in t(4;14)+ MM.

摘要

多发性骨髓瘤 SET 结构域(MMSET)蛋白在伴有 t(4;14)易位的多发性骨髓瘤(MM)患者中过度表达。尽管研究表明 MMSET/Wolf-Hirschhorn 综合征候选基因 1 参与了疾病的发展,但它在 MM 发病机制中的作用方式在很大程度上尚不清楚。我们发现 MMSET 是 t(4;14)MM 细胞中染色质结构和转录的主要调节剂。高水平的 MMSET 与组蛋白 H3 赖氨酸 36 甲基化增加和整个基因组赖氨酸 27 甲基化减少相关,导致染色质结构更开放。MMSET 表达的缺失改变了 MM 细胞的黏附特性,抑制了生长,并诱导了细胞凋亡。因此,受高水平 MMSET 影响的基因与 p53 途径、细胞周期调控和整合素信号转导有关。许多这些基因的调控需要 MMSET 的功能性组蛋白甲基转移酶活性。这些结果表明 MMSET 是 t(4;14)+ MM 中的主要表观遗传调节剂。

相似文献

1
The MMSET histone methyl transferase switches global histone methylation and alters gene expression in t(4;14) multiple myeloma cells.MMSET 组蛋白甲基转移酶在 t(4;14)多发性骨髓瘤细胞中切换全局组蛋白甲基化并改变基因表达。
Blood. 2011 Jan 6;117(1):211-20. doi: 10.1182/blood-2010-07-298349. Epub 2010 Oct 25.
2
MMSET stimulates myeloma cell growth through microRNA-mediated modulation of c-MYC.MMSET 通过 microRNA 介导的 c-MYC 调节促进骨髓瘤细胞生长。
Leukemia. 2013 Mar;27(3):686-94. doi: 10.1038/leu.2012.269. Epub 2012 Sep 13.
3
MMSET I acts as an oncoprotein and regulates GLO1 expression in t(4;14) multiple myeloma cells.MMSET I 作为一种癌蛋白,调节 t(4;14)多发性骨髓瘤细胞中的 GLO1 表达。
Leukemia. 2019 Mar;33(3):739-748. doi: 10.1038/s41375-018-0300-0. Epub 2018 Nov 23.
4
MMSET deregulation affects cell cycle progression and adhesion regulons in t(4;14) myeloma plasma cells.MMSET失调影响t(4;14) 骨髓瘤浆细胞的细胞周期进程和黏附调节子。
Haematologica. 2009 Jan;94(1):78-86. doi: 10.3324/haematol.13426. Epub 2008 Dec 4.
5
Histone methyltransferase MMSET/NSD2 alters EZH2 binding and reprograms the myeloma epigenome through global and focal changes in H3K36 and H3K27 methylation.组蛋白甲基转移酶MMSET/NSD2通过H3K36和H3K27甲基化的整体和局部变化改变EZH2结合并重新编程骨髓瘤表观基因组。
PLoS Genet. 2014 Sep 4;10(9):e1004566. doi: 10.1371/journal.pgen.1004566. eCollection 2014 Sep.
6
Overexpression of transcripts originating from the MMSET locus characterizes all t(4;14)(p16;q32)-positive multiple myeloma patients.源自MMSET基因座的转录本过表达是所有t(4;14)(p16;q32)阳性多发性骨髓瘤患者的特征。
Blood. 2005 May 15;105(10):4060-9. doi: 10.1182/blood-2004-09-3704. Epub 2005 Jan 27.
7
The multiple myeloma associated MMSET gene contributes to cellular adhesion, clonogenic growth, and tumorigenicity.与多发性骨髓瘤相关的MMSET基因有助于细胞黏附、克隆生长和致瘤性。
Blood. 2008 Jan 15;111(2):856-64. doi: 10.1182/blood-2007-05-088674. Epub 2007 Oct 17.
8
The t(4;14) translocation in myeloma dysregulates both FGFR3 and a novel gene, MMSET, resulting in IgH/MMSET hybrid transcripts.骨髓瘤中的t(4;14)易位使成纤维细胞生长因子受体3(FGFR3)和一个新基因MMSET均失调,从而产生免疫球蛋白重链(IgH)/MMSET融合转录本。
Blood. 1998 Nov 1;92(9):3025-34.
9
Identification of ID-1 as a potential target gene of MMSET in multiple myeloma.鉴定ID-1作为多发性骨髓瘤中MMSET的潜在靶基因。
Br J Haematol. 2005 Sep;130(5):700-8. doi: 10.1111/j.1365-2141.2005.05664.x.
10
The MMSET protein is a histone methyltransferase with characteristics of a transcriptional corepressor.MMSET蛋白是一种具有转录共抑制因子特征的组蛋白甲基转移酶。
Blood. 2008 Mar 15;111(6):3145-54. doi: 10.1182/blood-2007-06-092122. Epub 2007 Dec 21.

引用本文的文献

1
Identification and validation of a histone modification-related gene signature to predict the prognosis of multiple myeloma.用于预测多发性骨髓瘤预后的组蛋白修饰相关基因特征的鉴定与验证
Front Genet. 2025 Aug 28;16:1613631. doi: 10.3389/fgene.2025.1613631. eCollection 2025.
2
Discovery of a novel class NSD2 inhibitor for multiple myeloma with t(4;14).发现一种用于治疗伴有t(4;14)的多发性骨髓瘤的新型NSD2抑制剂。
Blood Neoplasia. 2025 Mar 11;2(2):100091. doi: 10.1016/j.bneo.2025.100091. eCollection 2025 May.
3
NSD2 inhibitors rewire chromatin to treat lung and pancreatic cancers.NSD2抑制剂通过重塑染色质来治疗肺癌和胰腺癌。
Nature. 2025 Aug 6. doi: 10.1038/s41586-025-09299-y.
4
Post-Translational Modifications in Multiple Myeloma: Mechanisms of Drug Resistance and Therapeutic Opportunities.多发性骨髓瘤中的翻译后修饰:耐药机制与治疗机遇
Biomolecules. 2025 May 12;15(5):702. doi: 10.3390/biom15050702.
5
ZMYND8 Reads H3K36me2 to Activate CEBPE Transcription and Suppress Multiple Myeloma Progression through the Inhibition of Adaptive UPR Pathways.ZMYND8 通过读取 H3K36me2 来激活 CEBPE 转录,并通过抑制适应性未折叠蛋白反应(UPR)途径来抑制多发性骨髓瘤进展。
Adv Sci (Weinh). 2025 May;12(20):e2409219. doi: 10.1002/advs.202409219. Epub 2025 May 10.
6
Epigenetic Plasticity Drives Carcinogenesis and Multi-Therapy Resistance in Multiple Myeloma.表观遗传可塑性驱动多发性骨髓瘤的致癌作用和多药耐药性。
Res Sq. 2025 Apr 15:rs.3.rs-6306816. doi: 10.21203/rs.3.rs-6306816/v1.
7
H3K36me2 methyltransferase NSD2/WHSC1 promotes triple-negative breast cancer metastasis via activation of ULK1-dependent autophagy.H3K36me2甲基转移酶NSD2/WHSC1通过激活ULK1依赖性自噬促进三阴性乳腺癌转移。
Autophagy. 2025 Mar 25:1-19. doi: 10.1080/15548627.2025.2479995.
8
HRP2 regulating MICU1-mediated Ca overload to dictate chemoresistance of multiple myeloma.HRP2通过调节MICU1介导的钙超载来决定多发性骨髓瘤的化疗耐药性。
Neoplasia. 2025 Apr;62:101150. doi: 10.1016/j.neo.2025.101150. Epub 2025 Mar 8.
9
The C-terminal PHDVC5HCH tandem domain of NSD2 is a combinatorial reader of unmodified H3K4 and tri-methylated H3K27 that regulates transcription of cell adhesion genes in multiple myeloma.NSD2的C末端PHDVC5HCH串联结构域是未修饰的H3K4和三甲基化H3K27的组合读取器,可调节多发性骨髓瘤中细胞粘附基因的转录。
Nucleic Acids Res. 2025 Jan 7;53(1). doi: 10.1093/nar/gkae1121.
10
Unveiling the potential of phytochemicals to inhibit nuclear receptor binding SET domain protein 2 for cancer: Pharmacophore screening, molecular docking, ADME properties, and molecular dynamics simulation investigations.揭示植物化学物质抑制核受体结合 SET 域蛋白 2 抑制癌症的潜力:药效团筛选、分子对接、ADME 性质和分子动力学模拟研究。
PLoS One. 2024 Aug 20;19(8):e0308913. doi: 10.1371/journal.pone.0308913. eCollection 2024.

本文引用的文献

1
Histone methyltransferase gene SETD2 is a novel tumor suppressor gene in clear cell renal cell carcinoma.组蛋白甲基转移酶基因 SETD2 是肾透明细胞癌中的一种新的肿瘤抑制基因。
Cancer Res. 2010 Jun 1;70(11):4287-91. doi: 10.1158/0008-5472.CAN-10-0120. Epub 2010 May 25.
2
CpG islands recruit a histone H3 lysine 36 demethylase.CpG 岛招募组蛋白 H3 赖氨酸 36 去甲基化酶。
Mol Cell. 2010 Apr 23;38(2):179-90. doi: 10.1016/j.molcel.2010.04.009.
3
Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species.磷酸化谷氨酰胺酶(GLS2),一种 p53 诱导的谷氨酰胺代谢和活性氧调节因子。
Proc Natl Acad Sci U S A. 2010 Apr 20;107(16):7461-6. doi: 10.1073/pnas.1002459107. Epub 2010 Mar 29.
4
Distinct factors control histone variant H3.3 localization at specific genomic regions.不同的因素控制着组蛋白变体 H3.3 在特定基因组区域的定位。
Cell. 2010 Mar 5;140(5):678-91. doi: 10.1016/j.cell.2010.01.003.
5
Deregulation of H3K27 methylation in cancer.癌症中 H3K27 甲基化的失调。
Nat Genet. 2010 Feb;42(2):100-1. doi: 10.1038/ng0210-100.
6
Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin.生发中心来源的滤泡性和弥漫性大 B 细胞淋巴瘤中 EZH2(Tyr641)改变的体细胞突变。
Nat Genet. 2010 Feb;42(2):181-5. doi: 10.1038/ng.518. Epub 2010 Jan 17.
7
The target of the NSD family of histone lysine methyltransferases depends on the nature of the substrate.组蛋白赖氨酸甲基转移酶NSD家族的作用靶点取决于底物的性质。
J Biol Chem. 2009 Dec 4;284(49):34283-95. doi: 10.1074/jbc.M109.034462. Epub 2009 Oct 6.
8
MLL fusions: pathways to leukemia.MLL 融合:白血病的发病途径。
Cancer Biol Ther. 2009 Jul;8(13):1204-11. doi: 10.4161/cbt.8.13.8924.
9
Nucleosomes are well positioned in exons and carry characteristic histone modifications.核小体在外显子中定位良好,并带有特征性的组蛋白修饰。
Genome Res. 2009 Oct;19(10):1732-41. doi: 10.1101/gr.092353.109. Epub 2009 Aug 17.
10
Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer.人类癌症中组蛋白H3K27去甲基化酶基因UTX的体细胞突变。
Nat Genet. 2009 May;41(5):521-3. doi: 10.1038/ng.349. Epub 2009 Mar 29.